It is caused by a pasture-based fungal toxin (sporidesmin) that when ingested, causes liver damage, decreased milk production and in severe cases, death.
Eczema-like breakouts and photosensitivity can also occur in a small proportion of affected animals.
Spelman said the breakthrough came at a critical time for the sector.
“The disease is linked to warmer, humid conditions - and February is when farmers start to observe the initial signs of eczema in their herds.
“In addition to this, we know climate change is increasing the disease’s range and prevalence, extending further inland and southward due to rising temperatures.
Spelman said the only current method to lessen the impact of facial eczema was preventive zinc dosing early in the year.
“Once liver damage occurs, there is no cure, only management, which involves removing affected animals from toxic pasture, providing shade, and allowing time for healing.
“Genetics is a long-term solution, so while the breeding value is incredibly exciting for the prevention of facial eczema in New Zealand dairy cows, it’s important that farmers continue their usual on-farm practices to mitigate the disease in their herd.”
Led by LIC, this research has been co-funded through the $25 million Resilient Dairy Programme, a Sustainable Food and Fibre Futures partnership with DairyNZ and the Ministry for Primary Industries.
The research aims to enhance the health and wellbeing of the national dairy herd through cutting-edge disease management technologies and genomic advancements.
As part of the Resilient Dairy Programme, LIC has invested more than $800,000 to improve animal wellness.
Developing a facial eczema breeding value, based on animals that have naturally acquired the disease, is the first outcome of this research.
LIC’s Resilient Dairy Programme manager Suzanne Young encouraged farmers facing facial eczema challenges to consider volunteering their herds for study.
“Our research is far from over,” Young said.
“Utilising additional data from working farms will help us to better understand facial eczema and continue to refine our tools to tackle this disease on farm.”